Projects and Grants per year
Grants and Contracts Details
Description
Background: Hepatocellular carcinoma (HCC) is the fifth most common cancer and third leading cause of
cancer deaths worldwide. While relatively rare in the US, HCC incidence is rising dramatically and becoming a
growing concern.
The primary risk factors for HCC in western countries are hepatitis C virus infection,
excessive alcohol consumption, and obesity-associated Non-Alcoholic Fatty Liver Disease (NAFLD); a major
reason for the rise of HCC in the US is the increase in obesity.
HCC is also one of the most lethal cancers, with
5-year survival rates of 5-8%, due, in part, to the late stages of diagnosis. Thus, an improved understanding of
HCC development and additional HCC biomarkers are needed to combat this increasingly important cancer.
.
Status | Finished |
---|---|
Effective start/end date | 12/21/18 → 12/20/19 |
Funding
- American Cancer Society
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Projects
- 1 Finished